Tetrabenazine Tablet
Product Images NDC 47335-277

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tetrabenazine (NDC 47335-277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-tetrabenazine-figure-1 (Spl Tetrabenazine Figure 1)

A line graph depicting mean changes in total chorea score from baseline over 14 study weeks in 84 Huntington's disease patients. Two groups are shown: Tetrabenazine (solid line) and Placebo (dashed line). The graph includes error bars representing ± standard error of the mean, with significant differences marked by asterisks (p<0.05). Patient numbers in each group are indicated at several time points. A washout period occurs after week 12.*

FDA Label Image

Spl-tetrabenazine-figure-2 (Spl Tetrabenazine Figure 2)

A cumulative percentage plot comparing Tetrabenazine and placebo groups based on change from baseline in total chorea score. The graph shows the cumulative percentage of patients achieving reductions in chorea score of 3, 6, and 10 points. Included is a legend with percentages of patients in each group reaching these thresholds, demonstrating higher efficacy in the Tetrabenazine group.*

FDA Label Image

Spl-tetrabenazine-label1 (Spl Tetrabenazine Label1)

Tetrabenazine Tablets 12.5 mg oral tablets packaging label displaying the NDC 47335-277-23. The label states each tablet contains 12.5 mg of tetrabenazine and includes storage instructions, dosage guidance, and a warning to keep out of reach of children. Distributed by Sun Pharmaceutical Industries, Inc., and manufactured by Sun Pharmaceutical Industries Limited in India. The package contains 112 tablets.*

FDA Label Image

Spl-tetrabenazine-label2 (Spl Tetrabenazine Label2)

Tetrabenazine Tablets 25 mg oral tablets label by Sun Pharmaceutical Industries, Inc. The label states the NDC 47335-179-23 and indicates 112 tablets per bottle. Storage instructions specify 20° to 25°C with permitted excursions. The label includes warnings about seal integrity, dispenser advice, and keeping medicines out of reach of children. Manufacturer and distributor details for Sun Pharmaceutical are also present.*

FDA Label Image

Spl-tetrabenazine-structure (Spl Tetrabenazine Structure)

Chemical structure of tetrabenazine, showing its molecular framework with methoxy groups and side chains as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.